On Friday, Apogee Therapeutics Inc (NASDAQ: APGE) opened higher 6.21% from the last session, before settling in for the closing price of $29.94. Price fluctuations for APGE have ranged from $26.20 to $63.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -51.71% at the time writing. With a float of $37.14 million, this company’s outstanding shares have now reached $45.99 million.
The extent of productivity of a business whose workforce counts for 196 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Apogee Therapeutics Inc (APGE) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Apogee Therapeutics Inc is 37.59%, while institutional ownership is 81.96%. The most recent insider transaction that took place on Apr 02 ’25, was worth 139,801. In this transaction Chief Medical Officer of this company sold 3,860 shares at a rate of $36.22, taking the stock ownership to the 247,173 shares. Before that another transaction happened on Apr 02 ’25, when Company’s Officer proposed sale 9,310 for $35.61, making the entire transaction worth $331,529.
Apogee Therapeutics Inc (APGE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -51.71% per share during the next fiscal year.
Apogee Therapeutics Inc (NASDAQ: APGE) Trading Performance Indicators
Check out the current performance indicators for Apogee Therapeutics Inc (APGE). In the past quarter, the stock posted a quick ratio of 18.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.23, a number that is poised to hit -1.24 in the next quarter and is forecasted to reach -5.99 in one year’s time.
Technical Analysis of Apogee Therapeutics Inc (APGE)
The latest stats from [Apogee Therapeutics Inc, APGE] show that its last 5-days average volume of 1.13 million was superior to 0.68 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.01%. Additionally, its Average True Range was 3.32.
During the past 100 days, Apogee Therapeutics Inc’s (APGE) raw stochastic average was set at 20.43%, which indicates a significant decrease from 37.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.47% in the past 14 days, which was higher than the 76.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.31, while its 200-day Moving Average is $45.32. Now, the first resistance to watch is $32.93. This is followed by the second major resistance level at $34.06. The third major resistance level sits at $36.23. If the price goes on to break the first support level at $29.64, it is likely to go to the next support level at $27.47. The third support level lies at $26.34 if the price breaches the second support level.
Apogee Therapeutics Inc (NASDAQ: APGE) Key Stats
There are currently 45,027K shares outstanding in the company with a market cap of 1.89 billion. Presently, the company’s annual sales total 0 K according to its annual income of -182,150 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -67,220 K.
